Your session is about to expire
← Back to Search
Antiplatelet Therapy for Cardiac Vasculopathy Post-Heart Transplant
Study Summary
This trial will study whether a common post-heart transplant medication can prevent a condition that narrows heart arteries and leads to graft dysfunction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a bleeding disorder.I cannot have a heart artery test due to low kidney function and I'm not on dialysis.I am 18 years old or older.I have been on blood thinners for more than 3 months.You had bleeding inside your head in the last 14 days.I have had a heart transplant.You are allergic to or cannot tolerate aspirin.I have had a solid organ transplant.You are allergic to or cannot tolerate clopidogrel.Your platelet count is less than 50,000 per microliter of blood.You have had bleeding or ulcers in your stomach related to taking aspirin in the past.I am taking antiplatelet medication for a reason other than heart issues.You are allergic to iodine-based dye used for medical tests.I cannot have a heart vessel exam because of my vein conditions.
- Group 1: aspirin
- Group 2: clopidogrel
- Group 3: placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many research subjects will be included in this investigation?
"The clinical trial is still open for recruitment, as of February 10th, 2022. This study was first posted on June 28th, 2021 and is looking for 135 patients from 3 locations."
When was aspirin cleared by the FDA?
"Aspirin is considered safe based on available data from Phase 3 clinical trials."
Is aspirin a common medication used in clinical trials?
"The aspirin clinical trials began in 2002 at Institut Curie Hopital. So far, 18924 studies have been completed with 205 currently active. Many of the ongoing research projects are based out of Vancouver, British Columbia."
Are there any patients who have not yet been enrolled in this research study?
"That is correct. As of February 10th, 2022, this study was still actively recruiting patients according to information found on clinicaltrials.gov. This research project was first posted on June 28th, 2021 and is enrolling 135 individuals from 3 locations."
What is the eventual goal of this clinical trial?
"The primary goal of this trial is to assess the feasibility of the treatment over a 3-year period. Secondary outcomes include measures of cardiac allograft vasculopathy, coronary macrovascular function, and platelet function."
Share this study with friends
Copy Link
Messenger